&nbsp;

jonathanFoster.jpg

Jul 2021

Regimen

CRBPPACL+PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Drugs Used:

Quick Link(s):

Regimen Monograph

Aug 2022

Document

ColoQMP-FacilityImprovementPlan.pdf

Jul 2021

Document

ColoQMP-PhysicianReport-PhysicianLearningPlan.pdf

Jul 2021

Document

CCOPEBCConflictInterestPolicy.pdf

Oct 2021

Regimen

CRBPPACL

Cancer Type:

Gynecologic,

Vulva

Intent: Palliative

Drugs Used:

PACLitaxel,

CARBOplatin

Quick Link(s):

Regimen Monograph, Patient Info Sheet (Every 3 weeks)

Jan 2024

Regimen

CAPM

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

capmatinib (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2021

Regimen

CARFCYCLDEXA

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

carfilzomib (Unfunded),

cyclophosphamide,

dexamethasone

Quick Link(s):

Regimen Monograph

Oct 2023

Regimen

CRBPPEME

Cancer Type:

Gastrointestinal

Intent: Palliative

Drugs Used:

pemetrexed,

CARBOplatin

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Dec 2023

Regimen

CRBPGEMC(W)+PEMB

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Locally Recurrent Unresectable or Metastatic Triple Negative Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2023

Regimen

CRBPPACL(W)

Cancer Type:

Breast

Intent: Neoadjuvant

Drugs Used:

PACLitaxel,

CARBOplatin

Quick Link(s):

Regimen Monograph

Nov 2021

Regimen

CISPETOP(PO)+DURV

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Durvalumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used: